An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival-Reference-Cited by-同舟云学术

An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival

Published:2011-12 Issue:12 Volume:22 Page:2625-2630
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Korse C.M.,Taal B.G.,Bonfrer J.M.G.,Vincent A.,van Velthuysen M.L.,Baas P.

Funder

Novartis Pharma B.V.

Abbott Diagnostics

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/12/2625/561331/mdr007.pdf

Reference33 articles.

1. Tumor markers in neuroendocrine tumors;Eriksson;Digestion,2000

2. Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report;Sondenaa;World J Surg,2004

3. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor;Korse;J Clin Oncol,2009

4. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine tumors;Korse;Neuroendocrinology,2009

5. False-positive serum chromogranin A assay due to heterophile antibody interference;Giovanella;Clin Chim Acta,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine Neoplasms;Endocrine Research;2024-07-23

2. Small Intestinal, Colorectal, and Appendicular Neuroendocrine Tumors;Neuroendocrine Tumours;2024

3. In Response;Journal of Thoracic Oncology;2023-11

4. Comment on “Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report”;Journal of Thoracic Oncology;2023-11

5. Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm;Cancers;2023-06-22